The Exoceuticals® team is counseled by an esteemed Advisory Board made up of world class Doctor, Scientists and Executives. Each of these exceptional individuals bring a wealth of knowledge and relationships that help Exoceuticals® be the premiere skincare brand that it is.


An avant-garde leader in regenerative medicine, stem cell, and biomaterials.

Mrs. Gurney is an innovative business and technology visionary with nearly two decades of dedicated efforts in Immunotherapy and Regenerative Medicine including cellular immune therapies, biomaterials, and tissue engineering. Spanning an industry career of 30+ years, she is a proven growth strategist and inspirational leader with an unwavering commitment to success through the development of transformative advanced therapeutics.

Read Full Bio

Focused upon her ambition to augment human immunity and longevity and to improve the human health span, Jodi was one of the first employees of Celularity, a clinical stage cell therapeutics company spun out of Celgene Corporation, which she helped to develop from its infancy. In her role as Chief Innovation Officer, she was integral in the success of numerous programs across discovery, development, commercialization, and acquisition in cancer immunotherapeutics, cell therapeutics and functional tissue regeneration.

During an 18-year tenure at Celgene, Ms. Gurney lead the Organ & Tissue Therapeutics Franchise and was responsible for both Clinical Research & Development and Medical Affairs for Celgene Cellular Therapeutics and LifebankUSA while also leading efforts to identify, develop and implement internal and external research, clinical and commercial collaborations for the entire Celgene Cellular Therapeutics portfolio.  She led and managed the entire Medical Affairs Research Program for Celgene Corporation including the multi-disciplinary investigator-initiated trial program involving Oncology, Inflammation, Immunology, Cellular Therapies and Biomaterials as well as the Disease Registry and Phase IV Programs.

Jodi created and ran the Celgene Inflammation and Immunology Clinical Science Program which was instrumental in developing the blockbuster OTEZLA® while laying the groundwork for the stand-alone Celgene Inflammation and Immunology Franchise which was acquired by Amgen for $13.4 Billion. Ms. Gurney joined Celgene in 1998 as one of the first field employees and was involved in the successful launch of THALOMID® as well as creation of the transformational REVLIMID® brand. 

Prior to joining Celgene and contributing to her +30 years of biotechnology / pharmaceutical industry experience, Ms. Gurney held positions in Medical Affairs for both Merck & Co./Ostex International and Parke-Davis. She received a M.S. in Biochemistry and B.S. in Biology from the University of Illinois in Urbana-Champaign.

Ms. Gurney has authored and contributed to dozens of publications covering her work in Immunology, Cellular Therapies and Technology as well as Biomaterials and Tissue Engineering and holds multiple patents in these fields.



A board certified cosmetic and reconstructive plastic surgeon

Dr. Randy Miller is a board certified cosmetic and reconstructive plastic surgeon practicing in Miami, Florida.  As one of the nation’s leading innovators in aesthetic surgery of the face, hand, breast and body, and a pioneer of reconstructive surgery and stem cell procedures, Dr. Miller is certified by the American Board of Plastic Surgery and the American Board of Otolaryngology – Head and Neck Surgery.

Read Full Bio

After earning a Bachelor of Arts in psychology and a master’s degree in clinical immunology, Dr. Miller completed medical school at Jefferson Medical College where he graduated at the top of his class. He completed his training in general surgery and otolaryngology - head and neck surgery at Thomas Jefferson University Hospital in Philadelphia. Dr. Miller performed his plastic surgery training at Baylor College of Medicine located within the Texas Medical Center in Houston, which is the largest medical center in the world.

Dr. Miller is a past president of the Miami Society of Plastic Surgeons, the Florida Society of Plastic Surgeons, and the Plastic Surgeons Patient Safety Foundation. He served five consecutive terms on the Board of Directors of the Dade County Medical Association and as a delegate to the Florida Medical Association. He is a member and has received presidential appointments from the American Society of Plastic Surgeons. Dr. Miller is a member of the Physician’s Council for the American Association of Tissue Banks.

In addition to his role as a clinical professor in the Division of Plastic Surgery at the University of Miami, Dr. Miller serves as a plastic surgery resident mentor. For many years he has served as the Liaison between the University of Miami, Division of Plastic Surgery, and the Miami Society of Plastic Surgeons.

Based on his research, publications and 25 years of clinical experience, Dr. Miller has become an internationally recognized expert in the fields of stem cell research and therapy, including human and veterinary tissue regeneration. He is the founder and director of, a peer-reviewed internet portal for accurate stem cell information. With his advanced regenerative platform, Dr. Miller provides a uniquely comprehensive approach to aesthetics and age management. In addition to plastic surgery, he collaborates extensively with experts in many other medical specialties.

Physicians and scientists from all over the world visit Miami to train with Dr. Miller. In addition to his network of collaborators from Europe, the Americas, India, Australia and the Middle East, Dr. Miller has lectured and performed surgery throughout Asia. He is the Ambassador to China for the American Society of Plastic Surgeons. Dr. Miller has also lectured by invitation at West Point.
Along with a group of regenerative medicine experts, Dr. Miller founded the American College of Regenerative Medicine (ACRM). This organization is the world’s first multispecialty interdisciplinary society for the safety and advancement of stem cells and regenerative medicine. ACRM includes physicians of all medical specialties, dentists and maxillofacial surgeons, veterinarians, coordinators and nurses and stem cell team members, basic science researchers, attorneys, and advocates.


World renowned, doctor, scientist, author, and thought leader.

Dr Li is a world-renowned physician, scientist, and New York Times bestselling author, known for his role as President and Medical Director of the Angiogenesis Foundation. His work has led to more than 40 FDA-approved therapeutics and devices for cancer, cardiovascular disease, wound healing, and vision loss.

Read Full Bio

Trained in the lab of Dr. Judah Folkman, pioneer of the angiogenesis field. He is actively engaged in global efforts to advance the applications of angiogenesis-based therapeutics across diverse medical fields, including oncology/hematology, cardiology, ophthalmology, vascular surgery, dermatology, wound care, and regenerative medicine. He has been published in Science, The New England Journal of Medicine, The Lancet, Nature Reviews, and other leading peer-reviewed medical journals. Dr Li’s TED talk on angiogenesis has received more than 11 million views.

Under Dr Li’s leadership, the Angiogenesis Foundation has developed a unique social enterprise model based on value creating collaborations with leading medical academic centers, biopharmaceutical and medical device companies, and government agencies, including the National Institutes of Health, Food and Drug Administration, and Centers for Medicare and Medicaid Services.

Dr. Li examines “food as medicine” through molecular nutrition, which applies biology and biotechnology to understand not only the components of food, but how the body responds to what it is fed. This pioneering approach leads to a deeper understanding of the cellular mechanisms responsible for the health benefits of food, and generates the scientific, clinical, and population-based evidence paving a way toward disease prevention, better fitness, and faster recovery from illness. He authored the book Eat to Beat Your Diet, which made the New York Times best seller list.

Dr Li received his A.B. with honors from Harvard College, and his M.D. from the University of Pittsburgh School of Medicine, Pennsylvania. He completed his internship, residency, and fellowship training in General Internal Medicine at the Massachusetts General Hospital in Boston. Will has held appointments on the clinical faculties of Harvard Medical School, Tufts University School of Veterinary Medicine, and Dartmouth Medical School. He serves as advisor and consultant to leading global public and private companies.


A leader in the retail industry and innovative product formulator.

Veronique Pinsky is a leader in the fragrance industry and have held senior positions at various global fashion and cosmetic brands. Ms. Pinsky is currently operating a specialty fragrance business and is a member Lifetime Brands board of directors (Nasdaq: LCUT), which is leading global designer, developer, and marketer of a broad range of branded consumer products.

Read Full Bio

She was President of Vera Wang Group from January 2016 through June 2018, after a year of consulting with the company and she oversaw all product categories and markets. Prior to joining Vera Wang, from 2006 to December 2014 Ms. Gabai-Pinsky was the Global President for Aramis and Designers Fragrances as well as Beauty Bank and Idea Bank at The Estée Lauder Companies, reporting to the Chief Executive Officer of such company.

During her tenure, Ms. Gabai-Pinsky developed and ensured the growth of several beauty and skin care brands, including Lab Series for Men. She was highly instrumental in the evolution of the fragrance category for such company, as she improved its overall business model, globally grew brands such as Donna Karan and Michael Kors, evolved and harmonized the portfolio, divested dilutive brands, and brought in Tory Burch, Zegna and Marni under licenses. She actively participated in the acquisitions of Le Labo, Frederic Malle, and By Kilian and assisted in the transformation of the long-term strategic direction of such company.

In the earlier years of her career, Ms. Gabai-Pinsky served as Vice President of Marketing and Communication for Guerlain, a division of LVMH Moet Hennessy Louis Vuitton S.A., where she led the successful re-launch of Shalimar, the introduction of Aqua Allegoria, and contributed to the re-focus of the beauty category around its pillars, Terracotta, Meteorites and Issima, while redesigning all communication strategies and content.

She started her career at L’Oréal, and was also Vice President of Marketing for Giorgio Armani, where she was instrumental in the overall development of its fragrance business by developing the successful Acqua di Gio for men and introducing the Emporio Armani franchise. A graduate from ESSEC Business School in Paris, France, she has received several awards, including Marketer of the Year by Women’s Wear Daily in December 2013.


Venerated physician, longevity expert and wellness disruptor.

Dr. Kapp is a dynamic entrepreneur who has founded several healthcare related businesses, ranging from surgical centers and hospitals to electronic health record systems and medical real estate development He is passionate about introducing cutting-edge technology to enhance both the facilities and operations of healthcare organizations.

Read Full Bio

Dr Kapp currently servs as the CEO of Fountain Life a data driven, transformative personalized health care clinic operator. Fountain Life and its network of physicians and scientists are constantly scanning the world searching for low-risk, high-reward therapeutic treatments.

As a board-certified orthopedic surgeon, former USAF Flight Surgeon, and type-rated jet aircraft pilot, Dr. Kapp has a unique combination of medical expertise and aviation knowledge. He is dedicated to advancing the new healthcare paradigm that focuses on the detection and reversal of asymptomatic diseases and strives to improve patient outcomes by leveraging the latest advancements in medical technology and innovation.

Dr. Kapp received his B.S. in Biochemistry from the University of Georgia and his M.S. in Immunology and M.D. at the Medical College of Georgia, where he graduated with honors and was inducted into Alpha Omega Alpha, the medical honor society. He attended the Baylor College of Medicine in Houston, Texas for residency in Orthopedic Surgery and completed his specialty training in 1994. He is a board-certified orthopedic surgeon and a Fellow in the American Academy of Orthopedic Surgeons. Until 2005, he served as flight surgeon in the US Air Force Reserves with the rank of Major and served as managing partner and leader for Physicians Alliance Surgery Center in Cape Girardeau, Missouri, a multi-specialty outpatient surgical center. Dr Kapp served as its Founding President and Medical Director from 2000 – 2003 and on its Medical Board from 2000 − 2011. Dr. Kapp also served as a managing partner for Orthopedic Associates of SE Missouri for over 15 years.

Previously, Dr Kapp had a vision to establish regional referral centers for medically complex patients requiring hospital-based post-acute care and founded and led as its Chairman and CEO, Longevity Bioimaging/Landmark Hospitals, in Naples, FL. Under his leadership, Landmark Hospitals grew into seven regional referral centers and implemented new information technologies that allow clinicians to easily document patient encounters and then follow and manage the patient upon discharge from our critical care hospitals across all post-acute settings, allowing for better outcomes and a seamless continuum of care.

Dr. Kapp has always looked for ways to lower the cost of medicine without sacrificing the delivery of care. He was the founding advisory board member of Missouri Physicians Mutual. MPM was founded in the late 1990’s as a Missouri-based 383 company to provide affordable medical malpractice insurance to a troubled market. MPM was able to grow from 10 physicians at its inception to well over 2,000, becoming the largest insurer in the state for physician medical malpractice insurance.


Renowned dermatologist and laser medicine pioneer

Dr. Goldberg earned his medical degree from Yale University School of Medicine. He completed his dermatology residency and dermatologic surgical fellowship at New York University Medical Center. He has served as President as well as Chairman of both the Ethics and International Committees of the American Society for Laser Medicine and Surgery (ASLMS).

Read Full Bio

Dr. Goldberg was the first ever recipient of the ASLMS Leon Goldman award named after the founder of laser medicine. He has served on the Board of Directors of the American Academy of Dermatology, the American Society for Dermatologic Surgery, the International Society of Dermatologic Surgery and the American Society of Lasers in Medicine and Surgery. He is also Director or Co-director of the annual 5CC meeting in Spain, the Aesthetic Extender Symposium in Florida, and the New Frontiers in Cosmetic Medicine meeting in New Jersey.

Dr. Goldberg is on the editorial boards of the Lasers in Surgery and Medicine and Dermatologic Surgery. He is current Senior Chief-Editor of the Journal of Cosmetic and Laser Therapy. Finally, Dr. Goldberg is an attorney and an Adjunct Professor of Law where he has taught a course entitled “Advances in Health Care Law.”